A Klinger1,2, M Kawata1,2, M Villalobos1,2, R B Jones1,2, S Pike1,2, N Wu1,2, S Chang1,2, P Zhang1,2, P DiMuzio3, J Vernengo4, P Benvenuto4, R D Goldfarb1,2, K Hunter1,2, Y Liu1,2, J P Carpenter1,2, T N Tulenko5. 1. Department of Surgery, Cooper University Hospital and Cooper Medical School at Rowan University, 3 Cooper Plaza, Camden, NJ, 08108, USA. 2. Department of Medicine, Cooper University Hospital and Cooper Medical School at Rowan University, Camden, NJ, USA. 3. Department of Surgery, Thomas Jefferson University, 1020 Walnut Street, Philadelphia, PA, 19107, USA. 4. Department of Chemical Engineering, Rowan University, 201 Mullica Hill Road, Glassboro, NJ, 08028, USA. 5. Department of Surgery, Cooper University Hospital and Cooper Medical School at Rowan University, 3 Cooper Plaza, Camden, NJ, 08108, USA. tulenko-thomas@cooperhealth.edu.
Abstract
BACKGROUND: Decellularized porcine small intestinal submucosa (SIS) is a biological scaffold used surgically for tissue repair. Here, we demonstrate a model of SIS as a scaffold for human adipose-derived stem cells (ASCs) in vitro and apply it in vivo in a rat ventral hernia repair model. STUDY DESIGN: ASCs adherence was examined by confocal microscopy and proliferation rate was measured by growth curves. Multipotency of ASCs seeded onto SIS was tested using adipogenic, chondrogenic, and osteogenic induction media. For in vivo testing, midline abdominal musculofascial and peritoneal defects were created in Sprague-Dawley rats. Samples were evaluated for tensile strength, histopathology and immunohistochemistry. RESULTS: All test groups showed cell adherence and proliferation on SIS. Fibronectin-treated scaffolds retained more cells than those treated with vehicle alone (p < 0.05). Fresh stromal vascular fraction (SVF) pellets containing ASCs were injected onto the SIS scaffold and showed similar results to cultured ASCs. Maintenance of multipotency on SIS was confirmed by lineage-specific markers and dyes. Histopathology revealed neovascularization and cell influx to ASC-seeded SIS samples following animal implantation. ASC-seeded SIS appeared to offer a stronger repair than plain SIS, but these results were not statistically significant. Immunohistochemistry showed continued presence of cells of human origin in ASC-seeded repairs at 1 month postoperation. CONCLUSION: Pretreatment of the scaffold with fibronectin offers a method to increase cell adhesion and delivery. ASCs maintain their immunophenotype and ability to differentiate while on SIS. Seeding freshly isolated SVF onto the scaffold demonstrated that minimally manipulated cells may be useful for perioperative surgical applications within the OR suite. We have shown that this model for a "living mesh" can be successfully used in abdominal wall reconstruction.
BACKGROUND: Decellularized porcine small intestinal submucosa (SIS) is a biological scaffold used surgically for tissue repair. Here, we demonstrate a model of SIS as a scaffold for human adipose-derived stem cells (ASCs) in vitro and apply it in vivo in a ratventral hernia repair model. STUDY DESIGN: ASCs adherence was examined by confocal microscopy and proliferation rate was measured by growth curves. Multipotency of ASCs seeded onto SIS was tested using adipogenic, chondrogenic, and osteogenic induction media. For in vivo testing, midline abdominal musculofascial and peritoneal defects were created in Sprague-Dawley rats. Samples were evaluated for tensile strength, histopathology and immunohistochemistry. RESULTS: All test groups showed cell adherence and proliferation on SIS. Fibronectin-treated scaffolds retained more cells than those treated with vehicle alone (p < 0.05). Fresh stromal vascular fraction (SVF) pellets containing ASCs were injected onto the SIS scaffold and showed similar results to cultured ASCs. Maintenance of multipotency on SIS was confirmed by lineage-specific markers and dyes. Histopathology revealed neovascularization and cell influx to ASC-seeded SIS samples following animal implantation. ASC-seeded SIS appeared to offer a stronger repair than plain SIS, but these results were not statistically significant. Immunohistochemistry showed continued presence of cells of human origin in ASC-seeded repairs at 1 month postoperation. CONCLUSION: Pretreatment of the scaffold with fibronectin offers a method to increase cell adhesion and delivery. ASCs maintain their immunophenotype and ability to differentiate while on SIS. Seeding freshly isolated SVF onto the scaffold demonstrated that minimally manipulated cells may be useful for perioperative surgical applications within the OR suite. We have shown that this model for a "living mesh" can be successfully used in abdominal wall reconstruction.
Entities:
Keywords:
Hernia; Mesenchymal stem cells; SIS; Small intestine submucosa
Authors: Stephen E McIlhenny; Eric S Hager; Daniel J Grabo; Christopher DiMatteo; Irving M Shapiro; Thomas N Tulenko; Paul J DiMuzio Journal: Tissue Eng Part A Date: 2010-01 Impact factor: 3.845
Authors: Tom T Chen; Alfonso Luque; Sunyoung Lee; Sean M Anderson; Tatiana Segura; M Luisa Iruela-Arispe Journal: J Cell Biol Date: 2010-02-22 Impact factor: 10.539
Authors: Henry L Chang; Tharanga N Senaratne; Lihua Zhang; Paul P Szotek; Ethan Stewart; David Dombkowski; Frederic Preffer; Patricia K Donahoe; Jose Teixeira Journal: Reprod Sci Date: 2009-10-05 Impact factor: 3.060
Authors: Elizabeth Brett; Natalie Chung; William Tripp Leavitt; Arash Momeni; Michael T Longaker; Derrick C Wan Journal: Tissue Eng Part B Rev Date: 2017-04-27 Impact factor: 6.389
Authors: Mijail D Serruya; James P Harris; Dayo O Adewole; Laura A Struzyna; Justin C Burrell; Ashley Nemes; Dmitriy Petrov; Reuben H Kraft; H Isaac Chen; John A Wolf; D Kacy Cullen Journal: Adv Funct Mater Date: 2017-09-04 Impact factor: 18.808
Authors: Erik T Criman; Wendy E Kurata; Karen W Matsumoto; Harry T Aubin; Carmen E Campbell; Lisa M Pierce Journal: Plast Reconstr Surg Glob Open Date: 2016-06-17